TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A. (2018)
Attributed to:
Maximising patient benefit: Leeds’ Interdisciplinary approach to translation (CiC 2017)
funded by
UKRI
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.25659
PubMed Identifier: 30038709
Publication URI: http://europepmc.org/abstract/MED/30038709
Type: Journal Article/Review
Volume: 9
Parent Publication: Oncotarget
Issue: 51
ISSN: 1949-2553